David A Federighi

Title: David A. Federighi: Innovator in Diagnostic Assays

Introduction

David A. Federighi is a notable inventor based in Kirkland, WA (US). He has made significant contributions to the field of medical diagnostics, particularly in the areas of sepsis and neoplasia. With a total of 2 patents, his work has the potential to impact patient care and treatment outcomes.

Latest Patents

Federighi's latest patents focus on innovative diagnostic assays. One patent addresses adult respiratory distress syndrome (ARDS), sepsis, multiple organ dysfunction (MOD), and systemic inflammatory response syndrome (SIRS). This diagnostic assay involves measuring the amounts of selected unsaturated and saturated free fatty acids (FFAs) in a body fluid and determining a ratio value of these fatty acids. Another patent pertains to a neoplasia diagnostic method, which measures the amounts of unsaturated FFAs, specifically linolenate and arachidonate, to determine the presence of a tumor burden in a mammal.

Career Highlights

David A. Federighi is currently associated with Cell Therapeutics, Inc., where he continues to develop and refine his innovative diagnostic methods. His work is characterized by a commitment to improving diagnostic accuracy and patient outcomes in critical medical conditions.

Collaborations

Federighi collaborates with various professionals in the field, including his coworker Stuart L. Bursten. These collaborations enhance the development and application of his diagnostic technologies.

Conclusion

David A. Federighi is a pioneering inventor whose work in diagnostic assays is making a significant impact in the medical field. His innovative approaches to diagnosing serious health conditions demonstrate his dedication to advancing healthcare technology.